D
Zevra Therapeutics, Inc. ZVRA
$8.31 $0.374.66%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue -6.79% 27.63% -47.47% 7.84% 538.97%
Total Other Revenue -- -- -- -- --
Total Revenue -6.79% 27.63% -47.47% 7.84% 538.97%
Cost of Revenue 11.33% 1,499.31% 427.77% 40.00% 5,477.27%
Gross Profit -8.69% -49.40% -88.76% 6.52% 484.65%
SG&A Expenses 4.82% 178.58% 90.62% 37.42% 188.61%
Depreciation & Amortization 109.33% -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -2.20% 69.78% 91.85% 49.38% 147.70%
Operating Income -1.71% -77.73% -280.60% -59.66% -62.75%
Income Before Tax -2.39% -226.05% -650.09% -25.32% -407.50%
Income Tax Expenses -- -- 194.59% 32.04% --
Earnings from Continuing Operations -79.67% -220.49% -674.39% -25.76% -445.95%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -79.67% -220.49% -674.39% -25.76% -445.95%
EBIT -1.71% -77.73% -280.60% -59.66% -62.75%
EBITDA 4.19% -67.88% -260.11% -48.40% -59.44%
EPS Basic -30.09% -132.83% -526.48% -3.75% -408.40%
Normalized Basic EPS 26.75% -134.64% -478.52% -1.71% -378.81%
EPS Diluted -30.09% -132.83% -526.48% -3.75% -408.40%
Normalized Diluted EPS 26.75% -134.64% -478.52% -1.71% -378.81%
Average Basic Shares Outstanding 38.11% 37.68% 23.60% 21.22% 12.20%
Average Diluted Shares Outstanding 38.11% 37.68% 23.60% 21.22% 12.20%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings